Filing Details

Accession Number:
0001062993-23-018551
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-09-27 20:50:14
Reporting Period:
2023-09-20
Accepted Time:
2023-09-27 20:50:14
Original Submission Date:
2023-09-22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1799011 Lucid Diagnostics Inc. LUCD () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1678195 Stanley Lapidus 360 Madison Avenue, 25Th Floor
New York NY 10017
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-09-20 3,405 $1.45 132,051 No 4 S Direct
Common Stock Disposition 2023-09-20 412 $1.44 131,639 No 4 S Direct
Common Stock Disposition 2023-09-21 100 $1.44 131,539 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
  2. Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.
  3. The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.